Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Change in Acquisitions & Divestments: 2018-2025

Historic Change in Acquisitions & Divestments for Abeona Therapeutics (ABEO) over the last 5 years, with Jun 2025 value amounting to $98.1 million.

  • Abeona Therapeutics' Change in Acquisitions & Divestments rose 473.46% to $98.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was $233.2 million, marking a year-over-year increase of 234.68%. This contributed to the annual value of $120.2 million for FY2024, which is 131.28% up from last year.
  • As of Q2 2025, Abeona Therapeutics' Change in Acquisitions & Divestments stood at $98.1 million, which was up 80.81% from $54.3 million recorded in Q1 2025.
  • Over the past 5 years, Abeona Therapeutics' Change in Acquisitions & Divestments peaked at $98.1 million during Q2 2025, and registered a low of $8.7 million during Q1 2022.
  • In the last 3 years, Abeona Therapeutics' Change in Acquisitions & Divestments had a median value of $19.7 million in 2024 and averaged $32.5 million.
  • As far as peak fluctuations go, Abeona Therapeutics' Change in Acquisitions & Divestments crashed by 65.32% in 2022, and later skyrocketed by 473.46% in 2025.
  • Abeona Therapeutics' Change in Acquisitions & Divestments (Quarterly) stood at $16.2 million in 2021, then plummeted by 44.99% to $8.9 million in 2022, then soared by 67.46% to $15.0 million in 2023, then skyrocketed by 100.22% to $30.0 million in 2024, then surged by 473.46% to $98.1 million in 2025.
  • Its Change in Acquisitions & Divestments was $98.1 million in Q2 2025, compared to $54.3 million in Q1 2025 and $30.0 million in Q4 2024.